Illumina, Inc. (ILMN)

128.91 -2.50 (-1.90%) At close: 04:00PM EDT

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
https://www.illumina.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 11,500

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Joydeep Goswami M.B.A., Ph.D.	CFO, Chief Strategy & Corp. Devel. Officer	787.3k	N/A	1971
Ms. Susan H. Tousi	Chief Commercial Officer	790.2k	N/A	1969
Mr. Charles E. Dadswell Esq.	Sr. VP & Gen. Counsel	N/A	N/A	1959
Stephanie Campos	Pres	N/A	N/A	N/A
Mr. Kevin Carl Pegels	Chief of Global Operations	N/A	N/A	1967
Mr. Scott Ericksen	VP & Chief Accounting Officer	N/A	N/A	1972
Dr. Steven Barnard Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Ms. Carissa L. Rollins	Chief Information Officer	N/A	N/A	1970
Ms. Sallilyn Schwartz	VP of Investor Relations	N/A	N/A	N/A
Ms. Kathryne Gambrell Reeves	Chief Marketing Officer	N/A	N/A	1969

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Corporate governance

Illumina, Inc.’s ISS governance QualityScore as of 1 September 2023 is 10. The pillar scores are Audit: 8; Board: 9; Shareholder rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.